Kory Wentworth
Director of Finance/CFO at ENTRADA THERAPEUTICS, INC.
Net worth: 219 884 $ as of 2024-04-29
Kory Wentworth active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director of Finance/CFO | 2020-10-31 | - |
| Treasurer | 2020-10-31 | - |
Career history of Kory Wentworth
Former positions of Kory Wentworth
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 2017-12-17 | 2020-09-07 |
| Treasurer | 2017-12-17 | 2020-10-01 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2017-10-31 | 2017-11-30 |
| Director/Board Member | 2011-12-31 | 2017-11-30 | |
| Corporate Officer/Principal | 2008-11-30 | 2017-11-30 |
Training of Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Kory Wentworth
- Experience
